These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30997364)

  • 1. Vibriocidal Titer and Protection From Cholera in Children.
    Ritter AS; Chowdhury F; Franke MF; Becker RL; Bhuiyan TR; Khan AI; Saha NC; Ryan ET; Calderwood SB; LaRocque RC; Harris JB; Qadri F; Weil AA
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz057. PubMed ID: 30997364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study.
    Wiens KE; Iyer AS; Bhuiyan TR; Lu LL; Cizmeci D; Gorman MJ; Yuan D; Becker RL; Ryan ET; Calderwood SB; LaRocque RC; Chowdhury F; Khan AI; Levine MM; Chen WH; Charles RC; Azman AS; Qadri F; Alter G; Harris JB
    Lancet Microbe; 2023 Apr; 4(4):e228-e235. PubMed ID: 36907197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Riyadh MA; Patel SM; Alam MM; Chowdhury F; Khan AI; Kalivoda EJ; Aktar A; Bhuiyan MS; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2011 Aug; 18(8):1317-25. PubMed ID: 21697337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.
    Harris JB; LaRocque RC; Chowdhury F; Khan AI; Logvinenko T; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    PLoS Negl Trop Dis; 2008 Apr; 2(4):e221. PubMed ID: 18398491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Hossain M; Tauheed I; Ahmed T; Islam S; Rafique TA; Siddique SA; Harun NB; Islam K; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007989. PubMed ID: 32176695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.
    Weil AA; Chowdhury F; Khan AI; Leung DT; Uddin T; Begum YA; Saha NC; Charles RC; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
    Am J Trop Med Hyg; 2012 Nov; 87(5):921-6. PubMed ID: 22964723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Tauheed I; Ahmed T; Ferdous J; Dash P; Basher SR; Hakim A; Lynch J; Kim JH; Excler JL; Kim DR; Clemens JD; Qadri F
    Vaccine; 2020 Feb; 38(7):1753-1761. PubMed ID: 31879124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.
    Kanungo S; Lopez AL; Ali M; Manna B; Kim DR; Mahapatra T; Holmgren J; Dhingra MS; Weirzba TF; Nair GB; Bhattacharya SK; Clemens JD; Sur D
    PLoS One; 2014; 9(5):e96499. PubMed ID: 24800828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.
    Haney DJ; Lock MD; Simon JK; Harris J; Gurwith M
    Clin Vaccine Immunol; 2017 May; 24(8):. PubMed ID: 28566334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
    Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
    Charles RC; Hilaire IJ; Mayo-Smith LM; Teng JE; Jerome JG; Franke MF; Saha A; Yu Y; Kováč P; Calderwood SB; Ryan ET; LaRocque RC; Almazor CP; Qadri F; Ivers LC; Harris JB
    PLoS Negl Trop Dis; 2014 May; 8(5):e2828. PubMed ID: 24786645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
    Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
    Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
    Islam K; Hossain M; Kelly M; Mayo Smith LM; Charles RC; Bhuiyan TR; Kováč P; Xu P; LaRocque RC; Calderwood SB; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB; Qadri F; Ryan ET
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006376. PubMed ID: 29624592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
    Aktar A; Rahman MA; Afrin S; Faruk MO; Uddin T; Akter A; Sami MIN; Yasmin T; Chowdhury F; Khan AI; Leung DT; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2016 May; 23(5):427-435. PubMed ID: 27009211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.